CJC-1295 vs FOXO4-DRI
Choosing between CJC-1295 and FOXO4-DRI? This comprehensive comparison breaks down everything you need to know about these two peptides, including their mechanisms, benefits, side effects, and which one might be right for you.
CJC-1295 is a Growth Hormone peptide while FOXO4-DRI belongs to the Senolytic category. This comparison helps you understand which might be better suited for your specific goals.
CJC-1295
CJC-1295 (with or without DAC)
growth-hormone
Phase 2 Clinical Trials
not-approved
- Muscle growth
- Recovery
- Anti-aging
FOXO4-DRI
FOXO4-D-Retro-Inverso
senolytic
Preclinical
not-approved
- Longevity
- Cellular cleanup
- Age reversal
Key Differences
- •CJC-1295 targets growth hormone while FOXO4-DRI focuses on senolytic
- •CJC-1295 primarily works through GH secretion and IGF-1 levels
- •FOXO4-DRI primarily works through senescent cell clearance
Similarities
- ✓Both require careful sourcing from reputable vendors
- ✓Both have limited long-term human safety data
- ✓Both are popular in the research peptide community
Detailed Comparison
| Aspect | CJC-1295 | FOXO4-DRI |
|---|---|---|
| Overview | A growth hormone releasing hormone (GHRH) analog that stimulates GH release. Available with DAC (Drug Affinity Complex) for extended half-life or without for shorter action.... | A promising senolytic peptide being researched for its potential to clear senescent ("zombie") cells to reverse aspects of biological aging. Showed dramatic results in aged mice.... |
| Primary Uses |
|
|
| Side Effects |
|
|
| Mechanism | Mimics GHRH to stimulate the pituitary gland to produce and release growth hormone. The DAC version binds to albumin for prolonged effect.... | Disrupts the interaction between FOXO4 and p53 in senescent cells, triggering apoptosis (cell death) specifically in these damaged cells while leaving... |
Frequently Asked Questions
Can I stack CJC-1295 and FOXO4-DRI together?
While some researchers do combine CJC-1295 and FOXO4-DRI, there's limited clinical data on their interaction. If considering a stack, start with lower doses and monitor for any adverse effects. Always consult with a healthcare provider before combining peptides.
Which is more effective, CJC-1295 or FOXO4-DRI?
Effectiveness depends on your specific goals. CJC-1295 excels in growth hormone, while FOXO4-DRI is better suited for senolytic. Neither is universally "better" - it depends on what you're trying to achieve.
Is CJC-1295 safer than FOXO4-DRI?
Both peptides have different safety profiles and limited long-term human data. CJC-1295 and FOXO4-DRI each carry their own risks and potential side effects. Review the research and consult a healthcare provider to assess which might be more appropriate for your situation.
How do the costs of CJC-1295 and FOXO4-DRI compare?
Pricing varies significantly based on source, purity, and quantity. Generally, both peptides are available at similar price points on the research market, though FDA-approved versions (where applicable) are considerably more expensive.
Verdict
CJC-1295 and FOXO4-DRI serve different purposes - CJC-1295 for growth hormone and FOXO4-DRI for senolytic. Rather than choosing one over the other, consider which category aligns better with your current goals. Some researchers use both for complementary benefits.